|

DYNA-TEK, INC. (DTI) is a privately owned
company established in 1993, specializing in the development of
synthetic bodily fluids serving a growing plethora of clinical,
commercial, and research applications. Surineä,
a proprietary synthetic urine base registered with the FDA, was the
first synthetic product created and continues to generate an increasing
market share base because of its unique characteristics. DTI is
now offering Oral Flx, our first proprietary entry into synthetic oral
fluids (synthetic saliva), with clear advantages in research and drug
detection applications. We have also introduced our first bacterial cell
lysis products, Ecolinox and Salmonox, which are used to detect the
presence of e coli and salmonella bacteria. Future product development
centers on synthetic serum and blood products. Our growth is enhanced by
the non-biological and non-hazardous natures of our products that are
odorless, foam free, and totally homogeneous, unlike natural bodily
fluids.
Our products pass
quickly through all customs checkpoints because of these
characteristics.
Kevin and Sandra
Dyches purchased DTI in 1999, and DTI has generated consistent growth
because of its unique products, quality service, and competitive
pricing. “We look to the future with optimism and excitement with
our growing product lines that assist in the development of new medical,
clinical, and commercial products in an ever-increasingly dangerous
world,” said Mr. Dyches. DTI’s client growing client list includes
government heavyweights like the Center for Disease Control and
Prevention (CDC and the FBI, SAMSHA-certified regional and national
labs, hospital labs, environmental labs, police labs, university
research centers, bio-tech pharmaceutical labs, state public health
labs, on-site drug and pregnancy kit manufacturers and distributors,
medical device manufacturers, mattress manufacturers, pet companies, and
fuel cell users, etc.
We are deeply indebted
to such industry notables as the following who have provided
encouragement, guidance, and oversight:
-
Dr.
David Roberts, Legacy Health Services
-
Dr. Stan
Kammerer, formerly of Clinical Reference Labs
-
Dr.
Robert Willette, DuoResearch
|